News tagged with types of cancer
Researchers find important 'target' playing role in tobacco-related lung cancers
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce ...
Feb 09, 2012 |
5 / 5 (1) |
0
Gene linked to pancreatic cancer growth, study finds
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer ...
Jan 31, 2012 |
not rated yet |
0
|
Compounds in mate tea induce death in colon cancer cells
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number ...
Jan 23, 2012 |
5 / 5 (1) |
0
Rigged to explode? Inherited mutation links exploding chromosomes to cancer
An inherited mutation in a gene known as the guardian of the genome is likely the link between exploding chromosomes and some particularly aggressive types of cancer, scientists at the European Molecular Biology ...
Jan 19, 2012 |
not rated yet |
0
Scientists find genetic key to why some cancer patients don't respond to treatment
(Medical Xpress) -- Researchers from Newcastle University have identified a gene variation carried by 20% of the population which can significantly affect how patients with a rare type of blood cancer will respond to treatment.
Jan 05, 2012 |
5 / 5 (1) |
0
Cancer-killing compound spares healthy cells
Lithocholic acid (LCA), naturally produced in the liver during digestion, has been seriously underestimated. A study published in the journal Oncotarget shows that LCA can kill several types of cancer cells, such as those ...
Jan 04, 2012 |
not rated yet |
1
|
Ovarian cancer study proves drug delays disease progression, may improve survival
Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, ...
Dec 28, 2011 |
not rated yet |
0
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic ...
Dec 28, 2011 |
not rated yet |
0
|
Tissue structure delays cancer development
Cancer growth normally follows a lengthy period of development. Over the course of time, genetic mutations often accumulate in cells, leading first to pre-cancerous conditions and ultimately to tumour growth. Using a mathematical ...
Dec 19, 2011 |
5 / 5 (2) |
0
|
Some muscular dystrophy patients at increased risk for cancer
People who have the most common type of adult muscular dystrophy also have a higher risk of getting cancer, according to a paper published today in the Journal of the American Medical Association.
Dec 13, 2011 |
not rated yet |
0
|
Male cancer patients turn to alternative treatments
(Medical Xpress) -- More than 50% of men diagnosed with cancer in Australia are turning to complementary and alternative medicine to help find a cure, or to improve their health, according to new research from the University ...
Dec 13, 2011 |
not rated yet |
0
Personalized treatment for Crohn's Disease a step closer following gene mapping
Three new locations for Crohn's Disease genes have been uncovered by scientists at UCL using a novel gene mapping approach.
Dec 08, 2011 |
not rated yet |
0
|
Acupuncture may ease severe nerve pain associated with cancer treatment
Acupuncture may help ease the severe nerve pain associated with certain cancer drugs, suggests a small preliminary study published in Acupuncture in Medicine.
Dec 06, 2011 |
not rated yet |
0
Tumor-specific pathway identified
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Nov 22, 2011 |
not rated yet |
0
|
Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors
Drug companies currently developing therapeutic cancer vaccines may be determining the cancers they target based on the number of annual cases, not the number of deaths they cause.
Nov 21, 2011 |
not rated yet |
0
